Stevanato Group S.p.A. $STVN Shares Sold by CenterBook Partners LP

CenterBook Partners LP trimmed its position in Stevanato Group S.p.A. (NYSE:STVN) by 41.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 61,758 shares of the company’s stock after selling 43,896 shares during the period. CenterBook Partners LP’s holdings in Stevanato Group were worth $1,590,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. First Horizon Advisors Inc. lifted its holdings in Stevanato Group by 14.9% during the 2nd quarter. First Horizon Advisors Inc. now owns 3,833 shares of the company’s stock worth $94,000 after buying an additional 497 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Stevanato Group by 7.7% during the 2nd quarter. PNC Financial Services Group Inc. now owns 9,893 shares of the company’s stock valued at $242,000 after acquiring an additional 711 shares in the last quarter. Van Berkom & Associates Inc. lifted its stake in Stevanato Group by 50.6% during the third quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after purchasing an additional 1,215 shares during the last quarter. Farther Finance Advisors LLC acquired a new position in Stevanato Group in the third quarter worth $44,000. Finally, First Horizon Corp acquired a new position in Stevanato Group in the third quarter worth $50,000.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on STVN. Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a report on Tuesday, February 10th. Wall Street Zen cut shares of Stevanato Group from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stevanato Group in a report on Monday, December 29th. Finally, Morgan Stanley initiated coverage on Stevanato Group in a research report on Monday, December 1st. They set an “equal weight” rating and a $24.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Stevanato Group Stock Performance

Shares of STVN stock opened at €16.30 on Friday. Stevanato Group S.p.A. has a 12-month low of €13.91 and a 12-month high of €28.00. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.89 and a quick ratio of 1.30. The firm has a market capitalization of $4.94 billion, a price-to-earnings ratio of 28.60, a price-to-earnings-growth ratio of 1.34 and a beta of 0.58. The business has a 50 day simple moving average of €18.71 and a 200 day simple moving average of €22.23.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.